$VTGN 👀 🔹 If PALISADE-4 hits, the big question becomes who wants fasedienol next? 🧠 🔹 My top logical contender would be Otsuka — major CNS / psychiatry foot

$VTGN 👀 🔹 If PALISADE-4 hits, the big question becomes who wants fasedienol next? 🧠 🔹 My top logical contender would be Otsuka — major CNS / psychiatry footprint and already built for mental health commercialization ⚡ 🔹 AbbVie and J&J also make sense, but Otsuka feels like the cleanest strategi…